Literature DB >> 9844689

Hepatic Doppler perfusion index: measurement in nine healthy volunteers.

R C Fowler1, K M Harris, S E Swift, M Ward, D C Greenwood.   

Abstract

Nine healthy volunteers were studied to validate the reproducibility of the Doppler perfusion index--the ratio of hepatic arterial to total liver blood flow--and to evaluate the method of its derivation and the influence of the variable parameters necessary for its calculation. Wide intraobserver variability was observed, and Doppler perfusion index values were consistently outside the previously reported normal range.

Mesh:

Year:  1998        PMID: 9844689     DOI: 10.1148/radiology.209.3.9844689

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Authors:  Y Tsushima; M J Blomley; H Yokoyama; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Diagnostic value of measuring liver volume for detecting occult hepatic metastases from colorectal or gastric cancer.

Authors:  Takeaki Ishizawa; Tetsuhisa Yamamoto; Koichiro Nishida; Hajime Tsukui; Takayoshi Sekikawa
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

3.  Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.

Authors:  Keiko Miyazaki; David J Collins; Simon Walker-Samuel; Jane N Taylor; Anwar R Padhani; Martin O Leach; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

4.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.